Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus | Zendy

Henry N. Ginsberg | Zendy; Marshall B. Elam | Zendy; Laura Lovato | Zendy; John R. Crouse | Zendy; Lawrence A. Leiter | Zendy; Peter E. Linz | Zendy; William T. Friedewald | Zendy; John B. Buse | Zendy; Hertzel C. Gerstein | Zendy; Jeffrey L. Probstfield | Zendy; Richard H. Grimm | Zendy; Faramarz Ismail-Beigi | Zendy; J. Thomas Bigger | Zendy; David C. Goff | Zendy; William C. Cushman | Zendy; Denise G. SimonsMorton | Zendy; Robert P. Byington | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

Author(s) -

Henry N. Ginsberg,

Marshall B. Elam,

Laura Lovato,

John R. Crouse,

Lawrence A. Leiter,

Peter E. Linz,

William T. Friedewald,

John B. Buse,

Hertzel C. Gerstein,

Jeffrey L. Probstfield,

Richard H. Grimm,

Faramarz Ismail-Beigi,

J. Thomas Bigger,

David C. Goff,

William C. Cushman,

Denise G. SimonsMorton,

Robert P. Byington

Publication year - 2010

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1001282

Subject(s) - medicine , fenofibrate , hazard ratio , simvastatin , fibrate , diabetes mellitus , placebo , myocardial infarction , type 2 diabetes mellitus , statin , type 2 diabetes , confidence interval , stroke (engine) , endocrinology , mechanical engineering , alternative medicine , pathology , engineering

We investigated whether combination therapy with a statin plus a fibrate, as compared with statin monotherapy, would reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus who were at high risk for cardiovascular disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research